nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—Cisplatin—testicular cancer	0.095	0.202	CbGbCtD
Betamethasone—PTGS2—Etoposide—testicular cancer	0.0933	0.198	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—testicular cancer	0.0545	0.116	CbGbCtD
Betamethasone—PGR—corpus luteum—testicular cancer	0.0397	0.224	CbGeAlD
Betamethasone—CYP3A4—Ifosfamide—testicular cancer	0.0386	0.082	CbGbCtD
Betamethasone—CYP19A1—corpus luteum—testicular cancer	0.0357	0.202	CbGeAlD
Betamethasone—ABCB1—Vinblastine—testicular cancer	0.0342	0.0726	CbGbCtD
Betamethasone—ABCB1—Cisplatin—testicular cancer	0.0313	0.0666	CbGbCtD
Betamethasone—ABCB1—Etoposide—testicular cancer	0.0308	0.0654	CbGbCtD
Betamethasone—CYP19A1—seminiferous tubule of testis—testicular cancer	0.0303	0.171	CbGeAlD
Betamethasone—ABCB1—Doxorubicin—testicular cancer	0.021	0.0446	CbGbCtD
Betamethasone—CYP3A4—Vinblastine—testicular cancer	0.0205	0.0435	CbGbCtD
Betamethasone—ABCB1—Methotrexate—testicular cancer	0.0203	0.0432	CbGbCtD
Betamethasone—CYP3A4—Etoposide—testicular cancer	0.0184	0.0392	CbGbCtD
Betamethasone—CYP19A1—semen—testicular cancer	0.0167	0.0945	CbGeAlD
Betamethasone—CYP3A4—Doxorubicin—testicular cancer	0.0126	0.0267	CbGbCtD
Betamethasone—PGR—Ovarian Infertility Genes—DAZL—testicular cancer	0.0105	0.316	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—DAZL—testicular cancer	0.00685	0.207	CbGpPWpGaD
Betamethasone—PLA2G1B—female gonad—testicular cancer	0.00503	0.0284	CbGeAlD
Betamethasone—PLA2G1B—testis—testicular cancer	0.00446	0.0252	CbGeAlD
Betamethasone—NR3C2—Preimplantation Embryo—DNMT3L—testicular cancer	0.00425	0.128	CbGpPWpGaD
Betamethasone—NR3C2—seminal vesicle—testicular cancer	0.00424	0.024	CbGeAlD
Betamethasone—CYP19A1—gonad—testicular cancer	0.00257	0.0145	CbGeAlD
Betamethasone—NR3C2—female gonad—testicular cancer	0.00249	0.0141	CbGeAlD
Betamethasone—NR3C1—embryo—testicular cancer	0.00242	0.0137	CbGeAlD
Betamethasone—PGR—female gonad—testicular cancer	0.00232	0.0131	CbGeAlD
Betamethasone—NR3C1—seminal vesicle—testicular cancer	0.00228	0.0129	CbGeAlD
Betamethasone—NR3C2—testis—testicular cancer	0.00221	0.0125	CbGeAlD
Betamethasone—NR3C1—Endoderm Differentiation—PRDM14—testicular cancer	0.00213	0.0644	CbGpPWpGaD
Betamethasone—PTGS2—embryo—testicular cancer	0.0021	0.0118	CbGeAlD
Betamethasone—CYP19A1—female gonad—testicular cancer	0.00208	0.0118	CbGeAlD
Betamethasone—PGR—testis—testicular cancer	0.00205	0.0116	CbGeAlD
Betamethasone—PTGS2—seminal vesicle—testicular cancer	0.00197	0.0111	CbGeAlD
Betamethasone—CYP19A1—testis—testicular cancer	0.00185	0.0104	CbGeAlD
Betamethasone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00169	0.0511	CbGpPWpGaD
Betamethasone—NR3C1—gonad—testicular cancer	0.00164	0.00929	CbGeAlD
Betamethasone—NR3C2—lymph node—testicular cancer	0.0016	0.00905	CbGeAlD
Betamethasone—PGR—lymph node—testicular cancer	0.00149	0.00841	CbGeAlD
Betamethasone—CYP19A1—lymph node—testicular cancer	0.00134	0.00757	CbGeAlD
Betamethasone—NR3C1—female gonad—testicular cancer	0.00134	0.00755	CbGeAlD
Betamethasone—ABCB1—embryo—testicular cancer	0.0013	0.00732	CbGeAlD
Betamethasone—ABCB1—seminal vesicle—testicular cancer	0.00122	0.00688	CbGeAlD
Betamethasone—NR3C1—testis—testicular cancer	0.00119	0.00669	CbGeAlD
Betamethasone—PTGS2—female gonad—testicular cancer	0.00116	0.00653	CbGeAlD
Betamethasone—ABCB1—gonad—testicular cancer	0.000881	0.00497	CbGeAlD
Betamethasone—NR3C1—lymph node—testicular cancer	0.000859	0.00485	CbGeAlD
Betamethasone—PTGS2—lymph node—testicular cancer	0.000744	0.0042	CbGeAlD
Betamethasone—ABCB1—female gonad—testicular cancer	0.000716	0.00404	CbGeAlD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000653	0.0197	CbGpPWpGaD
Betamethasone—ABCB1—testis—testicular cancer	0.000635	0.00358	CbGeAlD
Betamethasone—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000611	0.0185	CbGpPWpGaD
Betamethasone—ABCB1—lymph node—testicular cancer	0.00046	0.0026	CbGeAlD
Betamethasone—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000423	0.0128	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—DNMT3L—testicular cancer	0.000391	0.0118	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—KITLG—testicular cancer	0.000385	0.0116	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000358	0.0108	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—HPGDS—testicular cancer	0.00034	0.0103	CbGpPWpGaD
Betamethasone—Fatigue—Ifosfamide—testicular cancer	0.000311	0.000973	CcSEcCtD
Betamethasone—Oedema—Cisplatin—testicular cancer	0.000311	0.000973	CcSEcCtD
Betamethasone—Anaphylactic shock—Cisplatin—testicular cancer	0.000311	0.000973	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00031	0.000972	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—testicular cancer	0.000309	0.000967	CcSEcCtD
Betamethasone—Infection—Cisplatin—testicular cancer	0.000309	0.000967	CcSEcCtD
Betamethasone—Pain—Ifosfamide—testicular cancer	0.000308	0.000965	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—testicular cancer	0.000308	0.000964	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—testicular cancer	0.000308	0.000963	CcSEcCtD
Betamethasone—Loss of consciousness—Etoposide—testicular cancer	0.000307	0.00096	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—testicular cancer	0.000307	0.00096	CcSEcCtD
Betamethasone—Nervous system disorder—Cisplatin—testicular cancer	0.000305	0.000954	CcSEcCtD
Betamethasone—Thrombocytopenia—Cisplatin—testicular cancer	0.000304	0.000953	CcSEcCtD
Betamethasone—Tachycardia—Cisplatin—testicular cancer	0.000303	0.00095	CcSEcCtD
Betamethasone—Asthenia—Bleomycin—testicular cancer	0.000303	0.000948	CcSEcCtD
Betamethasone—Convulsion—Etoposide—testicular cancer	0.000302	0.000947	CcSEcCtD
Betamethasone—Hypertension—Etoposide—testicular cancer	0.000301	0.000943	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—testicular cancer	0.0003	0.000941	CcSEcCtD
Betamethasone—Hyperhidrosis—Cisplatin—testicular cancer	0.0003	0.000941	CcSEcCtD
Betamethasone—Pruritus—Bleomycin—testicular cancer	0.000298	0.000935	CcSEcCtD
Betamethasone—Dry skin—Epirubicin—testicular cancer	0.000298	0.000932	CcSEcCtD
Betamethasone—Feeling abnormal—Ifosfamide—testicular cancer	0.000297	0.00093	CcSEcCtD
Betamethasone—Nausea—Vinblastine—testicular cancer	0.000297	0.000929	CcSEcCtD
Betamethasone—Anorexia—Cisplatin—testicular cancer	0.000296	0.000928	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—testicular cancer	0.000296	0.000926	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—testicular cancer	0.000296	0.000926	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—testicular cancer	0.000296	0.000925	CcSEcCtD
Betamethasone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000295	0.000923	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000295	0.00891	CbGpPWpGaD
Betamethasone—Discomfort—Etoposide—testicular cancer	0.000293	0.000919	CcSEcCtD
Betamethasone—Hypotension—Cisplatin—testicular cancer	0.00029	0.000909	CcSEcCtD
Betamethasone—Muscular weakness—Epirubicin—testicular cancer	0.000286	0.000897	CcSEcCtD
Betamethasone—Urticaria—Ifosfamide—testicular cancer	0.000286	0.000897	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—FGFR3—testicular cancer	0.000286	0.00866	CbGpPWpGaD
Betamethasone—Cardiac arrest—Doxorubicin—testicular cancer	0.000286	0.000895	CcSEcCtD
Betamethasone—Abdominal pain—Ifosfamide—testicular cancer	0.000285	0.000892	CcSEcCtD
Betamethasone—Body temperature increased—Ifosfamide—testicular cancer	0.000285	0.000892	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—testicular cancer	0.000285	0.000892	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—testicular cancer	0.000285	0.000891	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000283	0.000887	CcSEcCtD
Betamethasone—Infection—Etoposide—testicular cancer	0.000283	0.000886	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—testicular cancer	0.000282	0.000884	CcSEcCtD
Betamethasone—Paraesthesia—Cisplatin—testicular cancer	0.000279	0.000874	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—testicular cancer	0.000279	0.000873	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—testicular cancer	0.000278	0.00087	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—testicular cancer	0.000275	0.000862	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—testicular cancer	0.000275	0.000862	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.000274	0.0083	CbGpPWpGaD
Betamethasone—Hypokalaemia—Doxorubicin—testicular cancer	0.000273	0.000856	CcSEcCtD
Betamethasone—Anorexia—Etoposide—testicular cancer	0.000271	0.00085	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000271	0.0082	CbGpPWpGaD
Betamethasone—Decreased appetite—Cisplatin—testicular cancer	0.00027	0.000846	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—testicular cancer	0.000269	0.000843	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000268	0.00084	CcSEcCtD
Betamethasone—Vomiting—Bleomycin—testicular cancer	0.000268	0.00084	CcSEcCtD
Betamethasone—Hypotension—Etoposide—testicular cancer	0.000266	0.000833	CcSEcCtD
Betamethasone—Rash—Bleomycin—testicular cancer	0.000266	0.000833	CcSEcCtD
Betamethasone—Pain—Cisplatin—testicular cancer	0.000266	0.000832	CcSEcCtD
Betamethasone—Dermatitis—Bleomycin—testicular cancer	0.000266	0.000832	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—testicular cancer	0.000265	0.00083	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—KIT—testicular cancer	0.000263	0.00795	CbGpPWpGaD
Betamethasone—Conjunctivitis—Methotrexate—testicular cancer	0.00026	0.000814	CcSEcCtD
Betamethasone—Asthenia—Ifosfamide—testicular cancer	0.000259	0.00081	CcSEcCtD
Betamethasone—Feeling abnormal—Cisplatin—testicular cancer	0.000256	0.000802	CcSEcCtD
Betamethasone—Paraesthesia—Etoposide—testicular cancer	0.000256	0.000801	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—testicular cancer	0.000255	0.0008	CcSEcCtD
Betamethasone—Pruritus—Ifosfamide—testicular cancer	0.000255	0.000799	CcSEcCtD
Betamethasone—Weight decreased—Epirubicin—testicular cancer	0.000254	0.000795	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—testicular cancer	0.000253	0.000793	CcSEcCtD
Betamethasone—Nausea—Bleomycin—testicular cancer	0.000251	0.000785	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—testicular cancer	0.00025	0.000783	CcSEcCtD
Betamethasone—Rash—Dactinomycin—testicular cancer	0.000248	0.000777	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—testicular cancer	0.000248	0.000775	CcSEcCtD
Betamethasone—Diarrhoea—Ifosfamide—testicular cancer	0.000247	0.000772	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000246	0.00077	CcSEcCtD
Betamethasone—Body temperature increased—Cisplatin—testicular cancer	0.000246	0.000769	CcSEcCtD
Betamethasone—Fatigue—Etoposide—testicular cancer	0.000245	0.000769	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000245	0.000768	CcSEcCtD
Betamethasone—Pain—Etoposide—testicular cancer	0.000243	0.000762	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—testicular cancer	0.000243	0.000762	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—testicular cancer	0.000241	0.000756	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—testicular cancer	0.00024	0.000752	CcSEcCtD
Betamethasone—Dizziness—Ifosfamide—testicular cancer	0.000238	0.000747	CcSEcCtD
Betamethasone—PGR—Gene Expression—DNMT3L—testicular cancer	0.000238	0.00721	CbGpPWpGaD
Betamethasone—Weight increased—Doxorubicin—testicular cancer	0.000236	0.00074	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—testicular cancer	0.000235	0.000736	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—testicular cancer	0.000235	0.000735	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000234	0.000734	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—testicular cancer	0.000234	0.000732	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—testicular cancer	0.000233	0.000729	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—testicular cancer	0.000231	0.000724	CcSEcCtD
Betamethasone—Vomiting—Ifosfamide—testicular cancer	0.000229	0.000718	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—testicular cancer	0.000229	0.000716	CcSEcCtD
Betamethasone—Rash—Ifosfamide—testicular cancer	0.000227	0.000712	CcSEcCtD
Betamethasone—Dermatitis—Ifosfamide—testicular cancer	0.000227	0.000711	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000227	0.000711	CcSEcCtD
Betamethasone—Urticaria—Etoposide—testicular cancer	0.000226	0.000708	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—testicular cancer	0.000226	0.000707	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—testicular cancer	0.000225	0.000705	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—testicular cancer	0.000225	0.000705	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—testicular cancer	0.000225	0.000705	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—testicular cancer	0.000225	0.000704	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—testicular cancer	0.000224	0.000703	CcSEcCtD
Betamethasone—Asthenia—Cisplatin—testicular cancer	0.000223	0.000698	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—testicular cancer	0.000218	0.000682	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—testicular cancer	0.000216	0.000678	CcSEcCtD
Betamethasone—Nausea—Ifosfamide—testicular cancer	0.000214	0.000671	CcSEcCtD
Betamethasone—Diarrhoea—Cisplatin—testicular cancer	0.000213	0.000666	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—testicular cancer	0.000212	0.000664	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—testicular cancer	0.000212	0.000663	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—testicular cancer	0.00021	0.000657	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000209	0.00632	CbGpPWpGaD
Betamethasone—Erythema—Methotrexate—testicular cancer	0.000209	0.000654	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—testicular cancer	0.000209	0.000654	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—testicular cancer	0.000208	0.000651	CcSEcCtD
Betamethasone—Asthenia—Etoposide—testicular cancer	0.000204	0.00064	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—testicular cancer	0.000204	0.000638	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000202	0.0061	CbGpPWpGaD
Betamethasone—Pruritus—Etoposide—testicular cancer	0.000201	0.000631	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—testicular cancer	0.000201	0.000628	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—testicular cancer	0.0002	0.000627	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—testicular cancer	0.000199	0.000622	CcSEcCtD
Betamethasone—Vomiting—Cisplatin—testicular cancer	0.000198	0.000619	CcSEcCtD
Betamethasone—Rash—Cisplatin—testicular cancer	0.000196	0.000614	CcSEcCtD
Betamethasone—Dermatitis—Cisplatin—testicular cancer	0.000196	0.000613	CcSEcCtD
Betamethasone—Erythema—Epirubicin—testicular cancer	0.000196	0.000612	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—testicular cancer	0.000195	0.00061	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—testicular cancer	0.000194	0.000608	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—testicular cancer	0.000194	0.000607	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—testicular cancer	0.000189	0.000591	CcSEcCtD
Betamethasone—Malaise—Methotrexate—testicular cancer	0.000188	0.00059	CcSEcCtD
Betamethasone—Dizziness—Etoposide—testicular cancer	0.000188	0.00059	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—testicular cancer	0.000188	0.000588	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—testicular cancer	0.000186	0.000582	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000185	0.00559	CbGpPWpGaD
Betamethasone—Nausea—Cisplatin—testicular cancer	0.000185	0.000578	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—testicular cancer	0.000184	0.000575	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—testicular cancer	0.000181	0.000568	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—testicular cancer	0.000181	0.000567	CcSEcCtD
Betamethasone—Vomiting—Etoposide—testicular cancer	0.000181	0.000567	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—testicular cancer	0.000181	0.000567	CcSEcCtD
Betamethasone—Rash—Etoposide—testicular cancer	0.00018	0.000562	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—testicular cancer	0.000179	0.000562	CcSEcCtD
Betamethasone—Headache—Etoposide—testicular cancer	0.000178	0.000559	CcSEcCtD
Betamethasone—Myalgia—Methotrexate—testicular cancer	0.000178	0.000557	CcSEcCtD
Betamethasone—Malaise—Epirubicin—testicular cancer	0.000176	0.000552	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—testicular cancer	0.000176	0.00055	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—testicular cancer	0.000176	0.00055	CcSEcCtD
Betamethasone—Syncope—Epirubicin—testicular cancer	0.000175	0.000549	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—testicular cancer	0.000172	0.000538	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—testicular cancer	0.000171	0.000534	CcSEcCtD
Betamethasone—Convulsion—Epirubicin—testicular cancer	0.000169	0.000531	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—INSL3—testicular cancer	0.000169	0.00512	CbGpPWpGaD
Betamethasone—Infection—Methotrexate—testicular cancer	0.000169	0.000531	CcSEcCtD
Betamethasone—Nausea—Etoposide—testicular cancer	0.000169	0.00053	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—testicular cancer	0.000169	0.000529	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000168	0.000526	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—testicular cancer	0.000167	0.000524	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—testicular cancer	0.000167	0.000523	CcSEcCtD
Betamethasone—Myalgia—Epirubicin—testicular cancer	0.000166	0.000521	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—testicular cancer	0.000166	0.00052	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—testicular cancer	0.000165	0.000516	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—testicular cancer	0.000164	0.000515	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—testicular cancer	0.000163	0.000511	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—testicular cancer	0.000163	0.000509	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—testicular cancer	0.000163	0.000509	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—testicular cancer	0.000162	0.000508	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000162	0.0049	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Epirubicin—testicular cancer	0.00016	0.0005	CcSEcCtD
Betamethasone—Oedema—Epirubicin—testicular cancer	0.00016	0.0005	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—testicular cancer	0.000159	0.000499	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—HPGDS—testicular cancer	0.000159	0.00482	CbGpPWpGaD
Betamethasone—Loss of consciousness—Doxorubicin—testicular cancer	0.000159	0.000498	CcSEcCtD
Betamethasone—Infection—Epirubicin—testicular cancer	0.000159	0.000497	CcSEcCtD
Betamethasone—Shock—Epirubicin—testicular cancer	0.000157	0.000492	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—testicular cancer	0.000157	0.000491	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—testicular cancer	0.000157	0.00049	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—testicular cancer	0.000156	0.000489	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—testicular cancer	0.000156	0.000489	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—testicular cancer	0.000156	0.000488	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000155	0.000487	CcSEcCtD
Betamethasone—Hyperhidrosis—Epirubicin—testicular cancer	0.000154	0.000483	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—testicular cancer	0.000154	0.000483	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—testicular cancer	0.000154	0.000482	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—testicular cancer	0.000154	0.000481	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—testicular cancer	0.000153	0.00048	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—testicular cancer	0.000152	0.000477	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—testicular cancer	0.000152	0.000476	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000152	0.00459	CbGpPWpGaD
Betamethasone—Dyspepsia—Methotrexate—testicular cancer	0.00015	0.00047	CcSEcCtD
Betamethasone—Hypotension—Epirubicin—testicular cancer	0.000149	0.000467	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—testicular cancer	0.000148	0.000464	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000148	0.00448	CbGpPWpGaD
Betamethasone—Oedema—Doxorubicin—testicular cancer	0.000148	0.000462	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000148	0.000462	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000147	0.000461	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—testicular cancer	0.000147	0.00046	CcSEcCtD
Betamethasone—Infection—Doxorubicin—testicular cancer	0.000147	0.000459	CcSEcCtD
Betamethasone—Pain—Methotrexate—testicular cancer	0.000146	0.000457	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000145	0.000455	CcSEcCtD
Betamethasone—Shock—Doxorubicin—testicular cancer	0.000145	0.000455	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—testicular cancer	0.000145	0.000454	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000145	0.000453	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—testicular cancer	0.000144	0.000452	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—testicular cancer	0.000144	0.000451	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—testicular cancer	0.000143	0.000449	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000143	0.000447	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—testicular cancer	0.000141	0.000441	CcSEcCtD
Betamethasone—Feeling abnormal—Methotrexate—testicular cancer	0.000141	0.00044	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—testicular cancer	0.00014	0.00044	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000139	0.000437	CcSEcCtD
Betamethasone—Decreased appetite—Epirubicin—testicular cancer	0.000139	0.000434	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—testicular cancer	0.000138	0.000432	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000138	0.000432	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—DNMT3L—testicular cancer	0.000138	0.00417	CbGpPWpGaD
Betamethasone—Fatigue—Epirubicin—testicular cancer	0.000138	0.000431	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—H2AFZ—testicular cancer	0.000137	0.00414	CbGpPWpGaD
Betamethasone—Pain—Epirubicin—testicular cancer	0.000136	0.000427	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—testicular cancer	0.000135	0.000424	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—testicular cancer	0.000135	0.000422	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—testicular cancer	0.000135	0.000422	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000135	0.000421	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—testicular cancer	0.000134	0.000418	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—testicular cancer	0.000133	0.000415	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—testicular cancer	0.000132	0.000412	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000131	0.00395	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000131	0.000409	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—testicular cancer	0.00013	0.000407	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—testicular cancer	0.000128	0.000402	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000127	0.000399	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—testicular cancer	0.000127	0.000399	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—testicular cancer	0.000127	0.000397	CcSEcCtD
Betamethasone—Pain—Doxorubicin—testicular cancer	0.000126	0.000395	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—testicular cancer	0.000126	0.000395	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—testicular cancer	0.000126	0.000395	CcSEcCtD
Betamethasone—Asthenia—Methotrexate—testicular cancer	0.000122	0.000383	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—testicular cancer	0.000122	0.000381	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000121	0.000378	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—testicular cancer	0.000121	0.000378	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—testicular cancer	0.000117	0.000367	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—testicular cancer	0.000117	0.000366	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—testicular cancer	0.000117	0.000366	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—testicular cancer	0.000117	0.000365	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—STK11—testicular cancer	0.000116	0.0035	CbGpPWpGaD
Betamethasone—Asthenia—Epirubicin—testicular cancer	0.000115	0.000359	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—testicular cancer	0.000113	0.000354	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—testicular cancer	0.000113	0.000353	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—testicular cancer	0.000109	0.000342	CcSEcCtD
Betamethasone—Vomiting—Methotrexate—testicular cancer	0.000108	0.00034	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000108	0.00326	CbGpPWpGaD
Betamethasone—Rash—Methotrexate—testicular cancer	0.000108	0.000337	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—testicular cancer	0.000107	0.000336	CcSEcCtD
Betamethasone—Headache—Methotrexate—testicular cancer	0.000107	0.000335	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—testicular cancer	0.000106	0.000332	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—testicular cancer	0.000106	0.000331	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—testicular cancer	0.000104	0.000327	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—testicular cancer	0.000101	0.000318	CcSEcCtD
Betamethasone—Nausea—Methotrexate—testicular cancer	0.000101	0.000317	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—testicular cancer	0.000101	0.000316	CcSEcCtD
Betamethasone—Rash—Epirubicin—testicular cancer	0.000101	0.000315	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—testicular cancer	0.000101	0.000315	CcSEcCtD
Betamethasone—Headache—Epirubicin—testicular cancer	0.0001	0.000313	CcSEcCtD
Betamethasone—CYP3A4—Biological oxidations—HPGDS—testicular cancer	9.93e-05	0.003	CbGpPWpGaD
Betamethasone—Dizziness—Doxorubicin—testicular cancer	9.77e-05	0.000306	CcSEcCtD
Betamethasone—Nausea—Epirubicin—testicular cancer	9.48e-05	0.000297	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—testicular cancer	9.39e-05	0.000294	CcSEcCtD
Betamethasone—Rash—Doxorubicin—testicular cancer	9.31e-05	0.000292	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—testicular cancer	9.3e-05	0.000291	CcSEcCtD
Betamethasone—Headache—Doxorubicin—testicular cancer	9.25e-05	0.00029	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—testicular cancer	8.77e-05	0.000275	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.73e-05	0.00264	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—H2AFZ—testicular cancer	8.34e-05	0.00252	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HPGDS—testicular cancer	5.82e-05	0.00176	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—H2AFZ—testicular cancer	5.42e-05	0.00164	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STK11—testicular cancer	5.39e-05	0.00163	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KITLG—testicular cancer	4.99e-05	0.00151	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—H2AFZ—testicular cancer	4.82e-05	0.00146	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—STK11—testicular cancer	4.23e-05	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HPGDS—testicular cancer	3.89e-05	0.00118	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGFR3—testicular cancer	3.71e-05	0.00112	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KIT—testicular cancer	3.4e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Disease—H2AFZ—testicular cancer	3.39e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KITLG—testicular cancer	3.12e-05	0.000944	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STK11—testicular cancer	2.82e-05	0.000854	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPGDS—testicular cancer	2.76e-05	0.000833	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR3—testicular cancer	2.32e-05	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KIT—testicular cancer	2.13e-05	0.000644	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STK11—testicular cancer	2e-05	0.000606	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPGDS—testicular cancer	1.7e-05	0.000513	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STK11—testicular cancer	1.23e-05	0.000373	CbGpPWpGaD
